GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (STU:41L) » Definitions » COGS-to-Revenue

Laboratorios Farmaceuticos Rovi (STU:41L) COGS-to-Revenue : 0.38 (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi COGS-to-Revenue?

Laboratorios Farmaceuticos Rovi's Cost of Goods Sold for the three months ended in Jun. 2024 was €67.8 Mil. Its Revenue for the three months ended in Jun. 2024 was €178.2 Mil.

Laboratorios Farmaceuticos Rovi's COGS to Revenue for the three months ended in Jun. 2024 was 0.38.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Laboratorios Farmaceuticos Rovi's Gross Margin % for the three months ended in Jun. 2024 was 61.92%.

Laboratorios Farmaceuticos Rovi COGS-to-Revenue Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi COGS-to-Revenue Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.43 0.41 0.36 0.41

Laboratorios Farmaceuticos Rovi Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.41 0.43 0.38 0.31

Laboratorios Farmaceuticos Rovi COGS-to-Revenue Calculation

Laboratorios Farmaceuticos Rovi's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=337.224 / 829.509
=0.41

Laboratorios Farmaceuticos Rovi's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=67.846 / 178.161
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi  (STU:41L) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Laboratorios Farmaceuticos Rovi's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 67.846 / 178.161
=61.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Laboratorios Farmaceuticos Rovi COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (STU:41L) » Definitions » COGS-to-Revenue
Comparable Companies
XMAD:PHM XMAD:ATRY XMAD:ORY XMAD:BST OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN
Traded in Other Exchanges
ROVI:Mexico ROVIe:UK 0ILL:UK ROVI:Spain
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Website
https://www.rovi.es
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi Headlines

No Headlines